Related Experiment Videos
Digoxin-quinidine interaction in unanesthetized guinea pigs
Pharmacology
|January 1, 1982
Summary
Quinidine significantly increases plasma digoxin levels by reducing its distribution into tissues. This drug interaction affects digoxin disposition but not its elimination half-life.
Area of Science:
- Pharmacology
- Drug Interactions
- Pharmacokinetics
Background:
- Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
- Quinidine is an antiarrhythmic drug that can interact with digoxin.
Purpose of the Study:
- To investigate the in vivo pharmacokinetic interaction between quinidine and digoxin.
- To determine the effect of quinidine on digoxin's plasma levels, volume of distribution, and elimination.
Main Methods:
- Unanesthetized and unrestrained guinea pigs were used for pharmacokinetic and tissue disposition studies.
- Digoxin (3H-digoxin) pharmacokinetics were assessed with and without quinidine administration.
- Plasma and tissue levels of digoxin were measured over time.
Main Results:
- Quinidine significantly elevated plasma digoxin levels within 5 minutes, persisting for at least 8 hours.
- The volume of distribution for digoxin decreased by 20% in quinidine-treated animals.
- Quinidine displaced digoxin from various tissues, evidenced by decreased tissue-to-plasma ratios.
Conclusions:
- Quinidine significantly alters digoxin pharmacokinetics, primarily by reducing its volume of distribution.
- The interaction is characterized by increased plasma digoxin concentrations due to tissue displacement, not altered elimination.
- Clinically relevant drug interactions between quinidine and digoxin necessitate careful patient monitoring.